The latest price target for Prestige Consumer (NYSE:PBH) was reported by Jefferies on February 2, 2026. The analyst firm set a price target for $66.00 expecting PBH to rise to within 12 months (a possible 25.91% upside). 5 analyst firms have reported ratings in the last year.

The latest analyst rating for Prestige Consumer (NYSE:PBH) was provided by Jefferies, and Prestige Consumer maintained their hold rating.

The last upgrade for Prestige Consumer Healthcare Inc happened on June 21, 2024 when DA Davidson raised their price target to $93. DA Davidson previously had a neutral for Prestige Consumer Healthcare Inc.

There is no last downgrade for Prestige Consumer.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Prestige Consumer, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Prestige Consumer was filed on February 2, 2026 so you should expect the next rating to be made available sometime around February 2, 2027.

While ratings are subjective and will change, the latest Prestige Consumer (PBH) rating was a maintained with a price target of $70.00 to $66.00. The current price Prestige Consumer (PBH) is trading at is $52.42, which is out of the analyst’s predicted range.